Investing Profile

Alexander Mayweg

InvestorVC

Managing Director at Versant Ventures

Photo of Alexander Mayweg, Managing Director at Versant Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Versant Ventures Managing Director
$100K - $5.0M
$1.5M
11
$102.2M
CompanyStageDateRound SizeTotal Raised
Vector BioPharma
Series AAug 2022$30M
$30M
Cimeio Therapeutics
Series AApr 2022$50M
$50M
T-knife
Series BAug 2021$110M
Series AAug 2020€66M
€74M
$110M
Co-investors: Olivier Litzka (Andera Partners)
Bright Peak Therapeutics
Series BJun 2021$110M
Series AJul 2020$35M
$140M
Co-investors: Tom Woiwode (Versant Ventures)
Matterhorn Biosciences
Venture RoundAug 2020$30M
$30M
Monte Rosa Therapeutics
Series AMay 2020$33M
$130M
Co-investors: Ali Behbahani (New Enterprise Associates (NEA)), Markus Warmuth (Versant Ventures), Andrew Schiff (Aisling Capital)
Black Diamond Therapeutics
Series CDec 2019$85M
Series BJan 2019$85M
Series ADec 2018$20M
$190M